Nader Sanai
Clinical trials sponsored by Nader Sanai, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug aims to reach brain tumors in recurrent glioblastoma Results expected Sep 2026 (estimated)
- New smart drug takes aim at Hard-to-Treat brain cancers Results expected Jul 2027 (estimated)
- Can a new pill reach brain tumors and halt their growth? Results expected Jul 2027 (estimated)
-
New drug combo shows promise in tough brain cancer
Disease control CompletedThis study tested a drug called pamiparib, given with radiation therapy, for people with a fast-growing brain cancer called glioblastoma. It included 50 patients, some newly diagnosed and some whose cancer had come back. The goal was to see how much drug reaches the tumor and whe…
Early phase 1 • Sponsor: Nader Sanai • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can combo drugs penetrate tough brain tumors? new study seeks answers
Knowledge-focused CompletedThis study looked at whether a combination of two drugs (LY3214996 and abemaciclib) can reach brain tumors in people with recurrent glioblastoma, a type of aggressive brain cancer. About 42 participants took the drugs before surgery to remove their tumor, and researchers measured…
Early phase 1 • Sponsor: Nader Sanai • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC